Ono Pharmaceutical Co., Ltd./ US6827361030 /
| 05/06/2024 21:52:36 | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.7700USD | - | 153,041 Turnover: 719,301.5464 |
-Bid Size: - | -Ask Size: - | 10.89 bill.USD | - | - |
Assets
|
2021 IFRS in mill. JPY |
||
|---|---|---|---|
| Property and Equipment | 112,131 | ||
| Intangible Assets | 64,734 | ||
| Long-Term Investments | 125,154 | ||
| Fixed Assets | 457,937 | ||
| Inventories | 41,817 | ||
| Accounts Receivable | 99,788 | ||
| Cash and Cash Equivalents | 69,112 | ||
| Current Assets | 281,266 | ||
| Total Assets | 739,203 | ||
Liabilities
|
2021 IFRS in mill. JPY |
||
|---|---|---|---|
| Accounts Payable | 49,689 | ||
| Long-term debt | - | ||
| Liabilities to Banks | - | ||
| Provisions | 1,009 | ||
| Liabilities | 77,529 | ||
| Share Capital | - | ||
| Total Equity | 655,906 | ||
| Minority Interests | 5,768 | ||
| Total liabilities equity | 739,203 | ||
Income Statement
|
2021 IFRS in mill. JPY |
||
|---|---|---|---|
| Revenues | 361,361 | ||
| Depreciation (total) | - | ||
| Operating Result | 103,195 | ||
| Interest Income | 1,836 | ||
| Income Before Taxes | - | ||
| Income Taxes | 24,340 | ||
| Minority Interests Profit | -166 | ||
| Net Income | 80,519 | ||
Per Share
Cash Flow
|
2021 IFRS in mill. JPY |
||
|---|---|---|---|
| Cash Flow from Operating Activities | 61,829 | ||
| Cash Flow from Investing Activities | 6,038 | ||
| Cash Flow from Financing | -60,237 | ||
| Decrease / Increase in Cash | - | ||
| Employees | 3,687 | ||
